Company-funded studies of approved drugs may not catch safety issues
By Lisa Rapaport(Reuters Health) – Studies drug companies fund after medicines go on sale may be too small to detect rare side effects, a recent Germ More »
By Lisa Rapaport(Reuters Health) – Studies drug companies fund after medicines go on sale may be too small to detect rare side effects, a recent Germ More »